Lista de obras - Lieping Chen - Dominio Público Uruguay

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

artículo científico publicado en 2015

Antibody gene therapy: old wine in a new bottle.

artículo científico publicado en 2002

B7-H1 agonists could prevent disseminated inflammation by desensitizing cell susceptibility to cytotoxic T-cells

scientific article published on 06 August 2018

B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.

artículo científico publicado en 2010

B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models

artículo científico publicado en 2019

B7-H4-deficient mice display augmented neutrophil-mediated innate immunity

artículo científico publicado en 2008

B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease

artículo científico publicado en 2014

Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.

artículo científico publicado en 2011

CD137 as a biomarker for tumor-reactive T cells: finding gold in the desert.

artículo científico publicado en 2013

CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype

artículo científico publicado en 2007

CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers

scientific article published on 05 November 2018

Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells

artículo científico publicado en 2012

Cell surface signaling molecules in the control of immune responses: a tide model.

artículo científico publicado en 2011

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

artículo científico publicado en 2017

Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma

scientific article published on 01 May 2003

Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens

artículo científico publicado en 2015

Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy.

artículo científico publicado en 2016

Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity

artículo científico publicado en 2014

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

artículo científico publicado en 2015

Control of autoimmune diseases by the B7-CD28 family molecules.

artículo científico publicado en 2004

Costimulation of T cells for tumor immunity.

artículo científico publicado en 1993

Costimulation of T-cell-mediated tumor immunity.

artículo científico publicado en 1996

Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus

artículo científico publicado en 2019

Fine tuning the immune response through B7-H3 and B7-H4

scientific article published on May 2009

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.

artículo científico publicado en 2015

From the guest editor: Tumor site immune modulation therapy.

artículo científico publicado en 2014

Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules.

artículo científico publicado en 2000

Immunological ignorance of silent antigens as an explanation of tumor evasion ⬇️

artículo científico publicado el 1 de enero de 1998

Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis

artículo científico publicado en 2016

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

artículo científico publicado en 2009

Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens

artículo científico publicado en 2015

Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM

artículo científico publicado en 2016

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

artículo científico publicado en 2019

PD-1 as an immune modulatory receptor.

artículo científico publicado en 2014

PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus

artículo científico publicado en 2019

PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing

artículo científico publicado en 2015

PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors.

artículo científico publicado en 2017

Predictors of responses to immune checkpoint blockade in advanced melanoma

artículo científico publicado en 2017

Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease

artículo científico publicado en 2014

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

artículo científico publicado en 2007

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy

artículo científico publicado en 2019

Structural insight into T cell coinhibition by PD-1H (VISTA)

scientific article published on 09 January 2020

The development and functions of CD4(+) T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope

scientific article published on 30 May 2011

The many sounds of T lymphocyte silence.

artículo científico publicado en 2005

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

artículo científico publicado en 2002

Turning the tide of lymphocyte costimulation.

artículo científico publicado en 2009

Lista de obras de Lieping Chen

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

Antibody gene therapy: old wine in a new bottle.

B7-H1 agonists could prevent disseminated inflammation by desensitizing cell susceptibility to cytotoxic T-cells

B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis.

B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models

B7-H4-deficient mice display augmented neutrophil-mediated innate immunity

B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease

Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells.

CD137 as a biomarker for tumor-reactive T cells: finding gold in the desert.

CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype

CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers

Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells

Cell surface signaling molecules in the control of immune responses: a tide model.

Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients.

Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma

Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens

Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy.

Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

Control of autoimmune diseases by the B7-CD28 family molecules.

Costimulation of T cells for tumor immunity.

Costimulation of T-cell-mediated tumor immunity.

Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus

Fine tuning the immune response through B7-H3 and B7-H4

Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb.

From the guest editor: Tumor site immune modulation therapy.

Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules.

Immunological ignorance of silent antigens as an explanation of tumor evasion ⬇️

Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis

Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions

Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens

Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM

Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression

PD-1 as an immune modulatory receptor.

PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus

PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing

PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors.

Predictors of responses to immune checkpoint blockade in advanced melanoma

Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy

Structural insight into T cell coinhibition by PD-1H (VISTA)

The development and functions of CD4(+) T cells expressing a transgenic TCR specific for an MHC-I-restricted tumor antigenic epitope

The many sounds of T lymphocyte silence.

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

Turning the tide of lymphocyte costimulation.